Blood collection devices market seen reaching $12.95 billion by 2030

The blood collection devices market is projected to grow from $8.48 billion in 2025 to $12.95 billion by 2030, driven by more diagnostic testing, chronic disease cases and wider use of automated and safety-engineered tools. North America led in 2025, while Asia-Pacific is expected to be the fastest-growing region as healthcare investment and diagnostic capacity expand.

Why it matters: - Blood collection devices are a core input for diagnostic testing, clinical research and drug development. - The market’s growth signals higher demand for blood-based testing as infectious disease, chronic disease and home diagnostics expand. - Faster adoption of safer and less invasive collection methods could improve patient comfort and infection control.

What happened: - The Business Research Company released a blood collection devices market report covering market size, trends and global forecasts for 2026 to 2035. - The market is expected to rise from $8.48 billion in 2025 to $9.26 billion in 2026. - The report projects the market will reach $12.95 billion by 2030. - The report pegs 2025 to 2026 growth at a 9.1% compound annual growth rate. - The report forecasts 2026 to 2030 growth at an 8.8% compound annual growth rate.

The details: - Higher diagnostic test volumes are a major growth driver. - Rising chronic disease cases are adding to demand. - More hospitals and diagnostic facilities are expanding the customer base. - Blood donation campaigns are contributing to device usage. - Standardized phlebotomy procedures are supporting broader adoption. - The market is also gaining from preference for minimally invasive sampling methods. - Automated blood collection devices are seeing wider adoption. - Home-based diagnostic solutions are expanding use cases. - Patient safety standards are becoming a stronger buying criterion. - New blood collection materials are advancing the technology base. - Emerging products include safety-engineered tools, automated systems, micro-volume sampling devices and single-use disposable products. - Infection control and patient comfort are getting more emphasis in product design. - Blood collection devices are used for health and wellness testing, population studies, clinical research and preclinical drug development. - The report said the devices matter because reliability and efficiency support accurate diagnostics and patient care. - A free sample of the report is available through the company’s sample page. - The full report is available through the company’s market report page. - The report’s 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.

Between the lines: - The forecast points to a market shifting from basic collection tools toward safer, more automated and more patient-friendly systems. - Infectious disease trends are reinforcing the need for routine blood testing, which supports steady device demand. - North America’s lead suggests mature infrastructure still matters, but Asia-Pacific’s faster growth indicates future demand may be tied to healthcare buildout and diagnostic access.

What’s next: - North America is expected to remain the largest regional market in 2025. - Asia-Pacific is projected to be the fastest-growing region through the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - Future market growth will likely track diagnostic expansion, home testing adoption and continued safety upgrades.

The bottom line: - Blood collection devices are moving from steady healthcare infrastructure to a faster-growing global market tied to diagnostics, automation and patient safety.